Pilot clinical trials testing the safety and effects on the metastatic melanoma microenvironment of intratumoral interferon-gamma or imiquimod, plus a multipeptide melanoma vaccine

Benzer Materyaller

• Topical treatment of melanoma metastases with imiquimod, plus administration of a cancer vaccine, promotes immune signatures in the metastases
  Yazar:: Mauldin, Ileana S., ve diğerleri
  Baskı/Yayın Bilgisi: (2016)
• Intratumoral interferon-gamma increases chemokine production but fails to increase T cell infiltration of human melanoma metastases
  Yazar:: Mauldin, Ileana S., ve diğerleri
  Baskı/Yayın Bilgisi: (2016)
• A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund’s adjuvant in melanoma patients
  Yazar:: Melssen, Marit M., ve diğerleri
  Baskı/Yayın Bilgisi: (2019)
• Randomized Multicenter Trial of the Effects of Melanoma-Associated Helper Peptides and Cyclophosphamide on the Immunogenicity of a Multipeptide Melanoma Vaccine
  Yazar:: Slingluff, Craig L., ve diğerleri
  Baskı/Yayın Bilgisi: (2011)
• Immunogenicity in humans of a transdermal multipeptide melanoma vaccine administered with or without a TLR7 agonist
  Yazar:: Meneveau, Max O, ve diğerleri
  Baskı/Yayın Bilgisi: (2021)